5-Hydroxydecanoate sodium
目录号: PL09983 纯度: ≥98.0%
CAS No. :71186-53-3
商品编号 规格 价格 会员价 是否有货 数量
PL09983-25mg 25mg ¥1854.55 请登录
PL09983-50mg 50mg ¥3090.91 请登录
PL09983-100mg 100mg 询价 询价
PL09983-200mg 200mg 询价 询价
PL09983-10mM*1mLinDMSO 10mM*1mLinDMSO ¥2040.00 请登录
Medlife所售产品仅用于科学研究(非临床研究),非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。产品COA等资料,可至下方“质量控制”中下载。
中文名称
5-Hydroxydecanoate sodium
中文别名
5-羟基癸酸钠盐;5-羟基癸酸钠
英文名称
5-Hydroxydecanoate sodium
英文别名
Decanoic acid,5-hydroxy-, sodium salt (1:1);5-HYDROXYDECANOIC ACID SODIUM SALT;5-HYDROXYDECANOATE NA;5-HYDROXYDECANOIC ACID SODIUM;5-Hydroxydecanoic acid sodium salt,5-hydroxydecanoate sodium salt;Sodium 5-hydroxydecanoate;5-hydroxydecanoate sodium salt;5-Hydroxydecanoate sodium
Cas No.
71186-53-3
分子式
C10H20O3.Na
分子量
211.25
包装储存
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
产品详情
5-Hydroxydecanoate sodium 是一种选择性 ATP 敏感的 K+ (KATP) 通道阻滞剂 (IC50 约为 30 μM)。5-Hydroxydecanoate sodium 是线粒体外膜酰基辅酶 A 合成酶的底物,并具有抗氧化活性。
生物活性
5-Hydroxydecanoate sodium is a selective ATP-sensitive K (K ATP ) channel blocker (IC 50 of ~30 μM). 5-Hydroxydecanoate sodium is a substrate for mitochondrial outer membrane acyl-CoA synthetase and has antioxidant activity.
性状
Solid
IC50 & Target[1][2]
IC50: ~30 μM (KATP)
体外研究(In Vitro)
5-Hydroxydecanoate (5-HD) treatment abolishs the beneficial effects of penehyclidine hydrochloride (PHC) preconditioning in anoxia/reoxygenation (A/R)‐induced injury in H9c2 cells. 5-Hydroxydecanoate blocks the inhibitory effect of PHC on Ca overload and ROS production. 5-Hydroxydecanoate promotes the release of Cyt-C from mitochondria into cytoplasm. 5-Hydroxydecanoate attenuats the anti-apoptotic effect of PHC. PHC treatment shows remarkably decreases levels of Bax and cleaved caspase-3, and increases levels of Bcl-2. 5-Hydroxydecanoate pretreatment reverses the effects of PHC on their expression levels. 5-Hydroxydecanoate blocks the effects of PHC on KATP channels. has not independently confirmed the accuracy of these methods. They are for reference only.
体内研究(In Vivo)
5-Hydroxydecanoate (100 μM) treatment abolishes the effects of ischemic preconditioning (IPC) on the contractile recovery and does not affect its effect on the contracture, lactate production, glycogenolysis and viable tissue in rats. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Congna Zi, et al. Penehyclidine hydrochloride protects against anoxia/reoxygenation injury in cardiomyocytes through ATP-sensitive potassium channels, and the Akt/GSK-3β and Akt/mTOR signaling pathways. Cell Biol Int. 2020 Jun;44(6):1353-1362.
[2]. Xiantao Li, et al. 5-Hydroxydecanoate and coenzyme A are inhibitors of native sarcolemmal KATP channels in inside-out patches. Biochim Biophys Acta. 2010 Mar;1800(3):385-91.
溶解度数据
In Vitro: DMSO : 12.5 mg/mL (59.45 mM; Need ultrasonic)H2O : 10 mg/mL (47.56 mM; Need ultrasonic)配制储备液
搜索质检报告(COA)

1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。

2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。

The molarity calculator equation
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)
The dilution calculator equation
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2